The Best Pot Stocks to Own if There’s a Marijuana Investing Rebound

One benefit of investing in a heavily beaten-down sector is that even a tiny glimmer of optimism in the market can trigger a robust short-term recovery.

| More on:
Pot stocks are a riskier investment

Image source: Getty Images

Marijuana/cannabis is easily one of the most beaten-down industries on the TSX. Its state wouldn’t have been as abysmal if the initial hype hadn’t set it rocketing upward in the early days. But those days are gone now, and many marijuana companies barely manage to stay in the green (financially), let alone grow.

There are glimmers of hope here and there, but nothing concrete that investors could rely upon to ensure that marijuana stocks will fully recover. Ironically, this uncertainty and partial hopelessness offer risk-tolerant investors a great opportunity. The odds against marijuana stocks are such that investors who bet on them might see exceptional returns if they make a decent recovery (not even a full recovery).

If that seems like an investment you might consider getting into, two weed stocks should be on your radar.

A U.S.-based cannabis company

Even though it came about as a merger of a Canadian and a U.S.-based company, Tilray (TSX:TLRY) is currently a U.S.-based company. Its primary focus is pharmaceutical/therapeutic research and products made with marijuana, but the company also has a recreational line of products.

However, the strongest point in the company’s favour is its global presence. It has multiple facilities in Canada and the U.S. (covering both markets) and is exporting its products to several countries around the globe. Penetrating the demanding European market alone is a considerable feat and may lead to fantastic growth opportunities in the future.

Tilray stock is relatively new, thanks to the merger, but it has already been doomed to the same fate as other stocks in the industry. It’s trading at an 85% discount from its 2021 peak. The good news is that if the stock manages to reach its former peak again in the future, you may grow your capital in the company by six- to seven-fold.

A Canada-based cannabis company

Canopy Growth (TSX:WEED) is one of the earliest giants of the marijuana industry, though it has been cut into a fraction of its former glory. The stock is currently trading at just $2.38 per share and has a market capitalization of $1.1 billion.

It used to trade at $67 per share at a time. If there is a remote possibility that the stock will reach that number again, it will lead to a 28 times growth of your capital if you buy it at the current price.

The company may have lost much of its market value, but some of its fundamental strengths remain. It has a decent U.S. presence that the company can leverage once marijuana is federally declared legal. It’s a well-known name in both medical marijuana and the recreational market and has grown its product portfolio to a decent size.

Foolish takeaway

In their current state, these do not even qualify as cyclical stocks. They show some positive activity when the market as a whole goes bullish, but triggering a solid recovery or at least a decently long period of growth might require something radical. U.S. marijuana legalization is a highly anticipated growth trigger for Canadian pot stocks right now.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »